124 related articles for article (PubMed ID: 20710057)
1. Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: role of didanosine.
Merchante N; Pérez-Camacho I; Mira JA; Rivero A; Macías J; Camacho A; Gómez-Mateos J; García-Lázaro M; Torre-Cisneros J; Pineda JA;
Antivir Ther; 2010; 15(5):753-63. PubMed ID: 20710057
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance.
Blanco F; Barreiro P; Ryan P; Vispo E; Martín-Carbonero L; Tuma P; Labarga P; Medrano J; González-Lahoz J; Soriano V
J Viral Hepat; 2011 Jan; 18(1):11-6. PubMed ID: 20088890
[TBL] [Abstract][Full Text] [Related]
3. Didanosine (ddI) associates with increased liver fibrosis in adult HIV-HCV coinfected patients.
Suárez-Zarracina T; Valle-Garay E; Collazos J; Montes AH; Cárcaba V; Carton JA; Asensi V
J Viral Hepat; 2012 Oct; 19(10):685-93. PubMed ID: 22967099
[TBL] [Abstract][Full Text] [Related]
4. The value of screening HIV-infected individuals for didanosine-related liver disease?
Scourfield A; Jackson A; Waters L; Gazzard B; Nelson M
Antivir Ther; 2011; 16(6):941-2. PubMed ID: 21900728
[No Abstract] [Full Text] [Related]
5. Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study.
Boubaker K; Flepp M; Sudre P; Furrer H; Haensel A; Hirschel B; Boggian K; Chave JP; Bernasconi E; Egger M; Opravil M; Rickenbach M; Francioli P; Telenti A
Clin Infect Dis; 2001 Dec; 33(11):1931-7. PubMed ID: 11692306
[TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
7. Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.
Walker UA; Bäuerle J; Laguno M; Murillas J; Mauss S; Schmutz G; Setzer B; Miquel R; Gatell JM; Mallolas J
Hepatology; 2004 Feb; 39(2):311-7. PubMed ID: 14767983
[TBL] [Abstract][Full Text] [Related]
8. Liver cirrhosis in HIV-infected patients: prevalence, aetiology and clinical outcome.
Castellares C; Barreiro P; Martín-Carbonero L; Labarga P; Vispo ME; Casado R; Galindo L; García-Gascó P; García-Samaniego J; Soriano V
J Viral Hepat; 2008 Mar; 15(3):165-72. PubMed ID: 18233989
[TBL] [Abstract][Full Text] [Related]
9. Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patients.
Vispo E; Maida I; Barreiro P; Moreno V; Soriano V
HIV Clin Trials; 2008; 9(6):440-4. PubMed ID: 19203910
[TBL] [Abstract][Full Text] [Related]
10. Nucleoside reverse-transcriptase inhibitor use, cirrhosis, and end-stage liver disease in HIV-infected patients.
Remtulla RA; Decker CF
Clin Infect Dis; 2008 Nov; 47(9):1233-4; author reply 1234. PubMed ID: 18831698
[No Abstract] [Full Text] [Related]
11. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
Guo JJ; Jang R; Louder A; Cluxton RJ
Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
[TBL] [Abstract][Full Text] [Related]
12. Distal sensory polyneuropathy in HIV-positive patients in the HAART era: an entity underestimated by clinical examination.
Skopelitis EE; Kokotis PI; Kontos AN; Panayiotakopoulos GD; Konstantinou K; Kordossis T; Karandreas N
Int J STD AIDS; 2006 Jul; 17(7):467-72. PubMed ID: 16820077
[TBL] [Abstract][Full Text] [Related]
13. Symptomatic hyperlactatemia in an HIV-positive patient: a case report and discussion.
Antoniou T; Weisdorf T; Gough K
CMAJ; 2003 Jan; 168(2):195-8. PubMed ID: 12538549
[TBL] [Abstract][Full Text] [Related]
14. Didanosine in HIV-1-infected patients experiencing failure of antiretroviral therapy: a randomized placebo-controlled trial.
Molina JM; Marcelin AG; Pavie J; Heripret L; De Boever CM; Troccaz M; Leleu G; Calvez V;
J Infect Dis; 2005 Mar; 191(6):840-7. PubMed ID: 15717257
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study.
Friis-Møller N; Weber R; Reiss P; Thiébaut R; Kirk O; d'Arminio Monforte A; Pradier C; Morfeldt L; Mateu S; Law M; El-Sadr W; De Wit S; Sabin CA; Phillips AN; Lundgren JD;
AIDS; 2003 May; 17(8):1179-93. PubMed ID: 12819520
[TBL] [Abstract][Full Text] [Related]
16. Progression of fibrosis in HIV and hepatitis C virus-coinfected patients treated with interferon plus ribavirin-based therapy: analysis of risk factors.
Bani-Sadr F; Lapidus N; Bedossa P; De Boever CM; Perronne C; Halfon P; Pol S; Carrat F; Cacoub P; ;
Clin Infect Dis; 2008 Mar; 46(5):768-74. PubMed ID: 18248298
[TBL] [Abstract][Full Text] [Related]
17. Heart attack risk with abacavir and didanosine.
AIDS Patient Care STDS; 2008 Apr; 22(4):346-7. PubMed ID: 18434947
[No Abstract] [Full Text] [Related]
18. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
Gatti F; Nasta P; Loregian A; Puoti M; Matti A; Pagni S; de Requena DG; Prestini K; Parisi SG; Bonora S; Palù G; Carosi G
J Antimicrob Chemother; 2009 Mar; 63(3):575-8. PubMed ID: 19151039
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.
Buffet M; Schwarzinger M; Amellal B; Gourlain K; Bui P; Prévot M; Deleuze J; Morini JP; Gorin I; Calvez V; Dupin N
J Clin Virol; 2005 May; 33(1):60-4. PubMed ID: 15797366
[TBL] [Abstract][Full Text] [Related]
20. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study.
Kovari H; Ledergerber B; Peter U; Flepp M; Jost J; Schmid P; Calmy A; Mueller NJ; Muellhaupt B; Weber R;
Clin Infect Dis; 2009 Aug; 49(4):626-35. PubMed ID: 19589079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
